搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
ophthalmologytimes
13 天
First patient dosed in clinical trial to treat neuropathic corneal pain
According to OKYO Pharma, OK-101 is the first drug candidate to enroll patients specifically diagnosed with neuropathic ...
USA TODAY on MSN
2 天
Here's why it's so important to catch and treat glaucoma early
Glaucoma is a group of eye diseases that cause slow, progressive damage to the optic nerve in the back of the eye ... in the eye to act as a drain for the excess fluid that is putting pressure on the ...
12 天
on MSN
How to Keep Your Vision Sharp
Cataracts, dry eyes, glaucoma, and other eye problems become more common with age. But these can be treated and even cured if ...
Nigerian Tribune
10 天
Is glaucoma curable?
My 60-year old Uncle was recently diagnosed with Glaucoma. Kindly let me know if the condition is curable.Silas (by ...
8 天
When one's vision is compromised, it is imperative to consult an eye specialist immediately
Injury to the eye can also cause sudden vision loss, said Dr Vinit Banga, director of neurology and head of neuro ...
12 天
on MSN
Protect Your Vision: Top strategies for preserving eye health
Our eyes are precious, allowing us to experience the world around us. Maintaining good eye health is crucial for a fulfilling ...
GlobalData on MSN
12 天
OKYO Pharma doses first subject in OK-101 Phase II trial for NCP
OKYO Pharma has initiated the Phase II trial of OK-101, a treatment for neuropathic corneal pain (NCP), by dosing the first ...
12 天
on MSN
Diabetes eye warning signs which can lead to sight damage - how to prevent it
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Yahoo Finance
16 小时
ADV Vision Introduces Groundbreaking iDose TR Treatment for Glaucoma Patients
Since mid-August, ADV Vision has successfully implanted the iDose TR in two patients, marking a new era in glaucoma treatment ...
13 天
OKYO Pharma Announces First Patient Dosed in the First Clinical Trial to Treat Neuropathic ...
OK-101 is the first drug candidate to enroll patients specifically diagnosed with Neuropathic Corneal Pain (NCP) in a clinical trialThe Phase 2 ...
Opinion
5 天
on MSN
Opinion
We must conquer type 2 diabetes - opinion
To truly conquer type 2 diabetes, we must implement the lifestyle changes that studies have overwhelmingly shown to be the ...
12 天
on MSN
Doctor warns seven high blood sugar signs that show up on your face
Over time, high blood sugar can lead to many health problems, including eye problems, kidney damage, nerve damage, and ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈